Journal article
Successful recruitment of monolingual Spanish speaking Latinos to university phase II and III outpatient COVID-19 clinical treatment trials in Northern California
Contemporary clinical trials, Vol.120, pp.106891-106891
09/01/2022
DOI: 10.1016/j.cct.2022.106891
PMID: 36002110
Abstract
Through a public County/University partnership, we employed a Spanish/English bilingual research coordinator to increase awareness of newly available treatments with FDA Emergency Use Authorization and clinical trial opportunities for Latino outpatients with mild to moderate COVID-19. Out of the 550 San Mateo County out-patients with COVID-19 referred to Stanford University between July 2020 and April 2022, 9.5% elected to receive monoclonal antibody EUA treatment. COVID-19 treatment trial enrollment of County patients, 5% of those recruited, was commensurate with non-County populations enrollment. Recruitment models such as ours have the potential to increase US Latino populations' recruitment in outpatient COVID-19 treatment trials and contribute to decreasing COVID-19 health disparities.
Details
- Title: Subtitle
- Successful recruitment of monolingual Spanish speaking Latinos to university phase II and III outpatient COVID-19 clinical treatment trials in Northern California
- Creators
- Vivian Levy - San Mateo Medical CenterRuth Yanes Bengoa - San Mateo Medical CenterPriscilla Padilla Romero - San Mateo Medical CenterJenna Bollyky - Stanford MedicineUpinder Singh - Stanford Medicine
- Resource Type
- Journal article
- Publication Details
- Contemporary clinical trials, Vol.120, pp.106891-106891
- DOI
- 10.1016/j.cct.2022.106891
- PMID
- 36002110
- NLM abbreviation
- Contemp Clin Trials
- ISSN
- 1551-7144
- eISSN
- 1559-2030
- Publisher
- Elsevier
- Number of pages
- 3
- Language
- English
- Date published
- 09/01/2022
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985244542002771
Metrics
1 Record Views